Literature DB >> 25912817

The dengue virus NS5 protein as a target for drug discovery.

Siew Pheng Lim1, Christian G Noble2, Pei-Yong Shi3.   

Abstract

The non-structural protein 5 (NS5) of flaviviruses is the most conserved amongst the viral proteins. It is about 900 kDa and bears enzymatic activities that play vital roles in virus replication. Its N-terminal domain encodes dual N7 and 2'-O methyltransferase activities (MTase), and possibly guanylyltransferase (GTase) involved in RNA cap formation. The C-terminal region comprises a RNA-dependent RNA polymerase (RdRp) required for viral RNA synthesis. Both MTase and RdRp activities of dengue virus NS5 are well characterized, structurally and functionally. Numerous crystal structures of the flavivirus MTase and RdRp domains have been solved. Inhibitors of both functions have been identified through screening activities using biochemical and cell-based assays, as well as via rational design approaches. This review summaries the current knowledge as well as prospective views on these aspects. This article forms part of a symposium on flavivirus drug discovery in Antiviral Research.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antiviral; Dengue hemorrhagic fever; Dengue virus; Methyltransferase; NS5 protein; RNA polymerase

Mesh:

Substances:

Year:  2015        PMID: 25912817     DOI: 10.1016/j.antiviral.2015.04.010

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  63 in total

1.  Identification and Characterization of Novel Broad-Spectrum Inhibitors of the Flavivirus Methyltransferase.

Authors:  Matthew Brecher; Hui Chen; Zhong Li; Nilesh K Banavali; Susan A Jones; Jing Zhang; Laura D Kramer; Hongmin Li
Journal:  ACS Infect Dis       Date:  2015-07-31       Impact factor: 5.084

Review 2.  Flavivirus RNA synthesis in vitro.

Authors:  Radhakrishnan Padmanabhan; Ratree Takhampunya; Tadahisa Teramoto; Kyung H Choi
Journal:  Methods       Date:  2015-08-10       Impact factor: 3.608

3.  Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors.

Authors:  Hong-Tao Xu; Said A Hassounah; Susan P Colby-Germinario; Maureen Oliveira; Clare Fogarty; Yudong Quan; Yingshan Han; Olga Golubkov; Ilinca Ibanescu; Bluma Brenner; Brent R Stranix; Mark A Wainberg
Journal:  J Antimicrob Chemother       Date:  2017-03-01       Impact factor: 5.790

Review 4.  Structure and function of Zika virus NS5 protein: perspectives for drug design.

Authors:  Boxiao Wang; Stephanie Thurmond; Rong Hai; Jikui Song
Journal:  Cell Mol Life Sci       Date:  2018-02-08       Impact factor: 9.261

Review 5.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Predicting Zika virus structural biology: Challenges and opportunities for intervention.

Authors:  Bryan D Cox; Richard A Stanton; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2016-06-13

Review 7.  Indole - a promising pharmacophore in recent antiviral drug discovery.

Authors:  Atukuri Dorababu
Journal:  RSC Med Chem       Date:  2020-11-06

Review 8.  Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.

Authors:  Veaceslav Boldescu; Mira A M Behnam; Nikos Vasilakis; Christian D Klein
Journal:  Nat Rev Drug Discov       Date:  2017-05-05       Impact factor: 84.694

9.  A Cyclic Phosphoramidate Prodrug of 2'-Deoxy-2'-Fluoro-2'-C-Methylguanosine for the Treatment of Dengue Virus Infection.

Authors:  Ratna Karuna; Fumiaki Yokokawa; Keshi Wang; Jin Zhang; Haoying Xu; Gang Wang; Mei Ding; Wai Ling Chan; Nahdiyah Abdul Ghafar; Andrea Leonardi; Cheah Chen Seh; Peck Gee Seah; Wei Liu; Rao P S Srinivasa; Siew Pheng Lim; Suresh B Lakshminarayana; Ellie Growcott; Sreehari Babu; Martijn Fenaux; Weidong Zhong; Feng Gu; Pei-Yong Shi; Francesca Blasco; Yen-Liang Chen
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

10.  Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.

Authors:  Hong-Tao Xu; Susan P Colby-Germinario; Said Hassounah; Peter K Quashie; Yingshan Han; Maureen Oliveira; Brent R Stranix; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.